Loading
Total declarations
Company
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Mar 2026 for Nautilus Biotechnology, Inc., €56k. Read the official filing
Filing timeline
BuySaleSujal M. Patel
Insider track record
Disclosed buys
9
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
+15.8%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Sujal M. Patel: trading record in brief
All filings by Sujal M. Patel on record concern Nautilus Biotechnology, Inc., in the capacity of chief executive. In total, 9 filings cover trades dated from 30 November 2021 to 4 March 2026.
The open-market record is one-sided, with 9 purchases worth €1.3M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 1 purchase and no sales on the market.
The median purchase comes to €67k. Clusters matter here: 2 out of 9 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
Most recently, on 4 March 2026, the filings show an open-market purchase worth €56k in Nautilus Biotechnology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sujal M. Patel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
25,000 shares@ US$2.60954.2% of flowCommon StockSEC:0001378830-26-000003:0
Canonical exit: 2 Jun 2026 (T+90)
116,500 shares@ US$0.67425.2% of flowCommon StockSEC:0001378830-25-000003:0
Canonical exit: 4 Dec 2025 (T+90)
53,300 shares@ US$0.99492.6% of flowCommon StockSEC:0001808805-25-000034:0
Canonical exit: 17 Jun 2025 (T+90)
2,430 shares@ US$2.98850.3% of flowCommon StockSEC:0001808805-24-000026:0
Canonical exit: 6 Jun 2024 (T+90)
7,405 shares@ US$2.64641.0% of flowCommon StockSEC:0001628280-24-009754:0
Canonical exit: 3 Jun 2024 (T+90)
41,654 shares@ US$2.92046.3% of flowCommon StockSEC:0001808805-22-000089:0
Canonical exit: 3 Nov 2022 (T+90)
50,000 shares@ US$3.9614.0% of flowCommon StockSEC:0001808805-22-000054:0
Canonical exit: 7 Aug 2022 (T+90)
50,000 shares@ US$3.597812.1% of flowCommon StockSEC:0001808805-22-000026:0
Canonical exit: 1 Jun 2022 (T+90)
161,978 shares@ US$4.721550.5% of flowCommon StockSEC:0001808805-21-000027:0
Canonical exit: 28 Feb 2022 (T+90)
9 of 9 declarations
